Financhill
Back

Leggett & Platt Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison

Sell
29

LEG
Leggett & Platt

Last Price:
14.12
Seasonality Move:
1.95%
Sell
18

CRBP
Corbus Pharmaceuticals Holdings

Last Price:
21.00
Seasonality Move:
-9.84%
Sell
29
Leggett & Platt (LEG) is a Sell

Is Leggett & Platt a Buy, Sell or Hold?

  • The current Leggett & Platt [LEG] share price is $13.61. The Score for LEG is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • LEG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Corbus Pharmaceuticals Holdings (CRBP) is a Sell

Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?

  • The current Corbus Pharmaceuticals Holdings [CRBP] share price is $21.51. The Score for CRBP is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • CRBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

LEG Stock Price Chart

What is Leggett & Platt's stock price today?

  • The Leggett & Platt share price today is $13.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LEG is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRBP Stock Price Chart

What is Corbus Pharmaceuticals Holdings's stock price today?

  • The Corbus Pharmaceuticals Holdings share price today is $21.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing slight selling pressure.

LEG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.29 Buy
Relative Strength Index (14 RSI): 60.99 Buy
Chaikin Money Flow: 758025 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.97 - 13.25) Buy
Bollinger Bands (100): (11.41 - 12.99) Buy

CRBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.8 Sell
Relative Strength Index (14 RSI): 26.98 Sell
Chaikin Money Flow: -481436 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.56 - 62.22) Sell
Bollinger Bands (100): (40.36 - 58.28) Sell

LEG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.29 Buy
20-day SMA: 12.6 Buy
50-day SMA: 12.63 Buy
200-day SMA: 16.79 Sell
8-day EMA: 13.23 Buy
20-day EMA: 12.85 Buy
50-day EMA: 12.67 Buy
200-day EMA: 16.34 Sell

CRBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.47 Sell
20-day SMA: 45.29 Sell
50-day SMA: 51.84 Sell
200-day SMA: 37.33 Sell
8-day EMA: 29.4 Sell
20-day EMA: 40.5 Sell
50-day EMA: 47.43 Sell
200-day EMA: 38.91 Sell

Leggett & Platt Earnings Growth & LEG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.26 per share, and an increase next year of $0.15 per share.

Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.64 per share, an increase this year of $6.97 per share, and a decrease next year of $0.83 per share.

Leggett & Platt Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corbus Pharmaceuticals Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):